DOD Biotech PCL (BKK:DOD) ROCE % : 0.03% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DOD Biotech PCL's annualized ROCE % for the quarter that ended in Dec. 2024 was 0.03%.

DOD Biotech PCL ROCE % Historical Data

The historical data trend for DOD Biotech PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL ROCE % Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

25.75

20.46

-35.43

9.08

4.22

DOD Biotech PCL Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															12.32	2.71	-71.02	9.33	0.03

DOD Biotech PCL ROCE % Calculation

DOD Biotech PCL's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	44.227	/	( ( (1457.639 - 282.798)	+	(1286.313 - 365.975) )	/ 2 )
	=	44.227	/	( (1174.841	+	920.338)	/ 2 )
	=	44.227	/	1047.5895
	=	4.22 %

DOD Biotech PCL's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	0.276	/	( ( (1229.923 - 300.633)	+	(1286.313 - 365.975) )	/ 2 )
	=	0.276	/	( ( 929.29	+	920.338 )	/ 2 )
	=	0.276	/	924.814
	=	0.03 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

DOD Biotech PCL (BKK:DOD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

DOD Biotech PCL ROCE % Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

DOD-R:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines